GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1)

 PRDM1_HUMAN             Reviewed;         825 AA.
O75626; B2REA6; E1P5E0; Q86WM7;
08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
18-MAY-2010, sequence version 2.
13-FEB-2019, entry version 172.
RecName: Full=PR domain zinc finger protein 1;
EC=2.1.1.-;
AltName: Full=BLIMP-1;
AltName: Full=Beta-interferon gene positive regulatory domain I-binding factor;
AltName: Full=PR domain-containing protein 1;
AltName: Full=Positive regulatory domain I-binding factor 1;
Short=PRDI-BF1;
Short=PRDI-binding factor 1;
Name=PRDM1; Synonyms=BLIMP1;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
PubMed=1851123; DOI=10.1101/gad.5.5.868;
Keller A.D., Maniatis T.;
"Identification and characterization of a novel repressor of beta-
interferon gene expression.";
Genes Dev. 5:868-879(1991).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), AND FUNCTION.
PubMed=12626569; DOI=10.4049/jimmunol.170.6.3125;
Gyory I., Fejer G., Ghosh N., Seto E., Wright K.L.;
"Identification of a functionally impaired positive regulatory domain
I binding factor 1 transcription repressor in myeloma cell lines.";
J. Immunol. 170:3125-3133(2003).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=14574404; DOI=10.1038/nature02055;
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
"The DNA sequence and analysis of human chromosome 6.";
Nature 425:805-811(2003).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
SUBCELLULAR LOCATION.
PubMed=21421998; DOI=10.1093/hmg/ddr114;
Julaton V.T., Reijo Pera R.A.;
"NANOS3 function in human germ cell development.";
Hum. Mol. Genet. 20:2238-2250(2011).
[7]
SUMOYLATION AT LYS-816.
PubMed=22555612; DOI=10.1038/embor.2012.60;
Ying H.Y., Su S.T., Hsu P.H., Chang C.C., Lin I.Y., Tseng Y.H.,
Tsai M.D., Shih H.M., Lin K.I.;
"SUMOylation of Blimp-1 is critical for plasma cell differentiation.";
EMBO Rep. 13:631-637(2012).
[8]
INTERACTION WITH FBXO10 AND FBXO11, AND UBIQUITINATION.
PubMed=24613396; DOI=10.1016/j.devcel.2014.01.028;
Horn M., Geisen C., Cermak L., Becker B., Nakamura S., Klein C.,
Pagano M., Antebi A.;
"DRE-1/FBXO11-dependent degradation of BLMP-1/BLIMP-1 governs C.
elegans developmental timing and maturation.";
Dev. Cell 28:697-710(2014).
[9]
INTERACTION WITH FBXO11.
PubMed=24968003; DOI=10.1371/journal.pgen.1004428;
Huang T.F., Cho C.Y., Cheng Y.T., Huang J.W., Wu Y.Z., Yeh A.Y.,
Nishiwaki K., Chang S.C., Wu Y.C.;
"BLMP-1/Blimp-1 regulates the spatiotemporal cell migration pattern in
C. elegans.";
PLoS Genet. 10:E1004428-E1004428(2014).
[10]
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-816, AND IDENTIFICATION BY
MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=28112733; DOI=10.1038/nsmb.3366;
Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
Nielsen M.L.;
"Site-specific mapping of the human SUMO proteome reveals co-
modification with phosphorylation.";
Nat. Struct. Mol. Biol. 24:325-336(2017).
[11]
X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 38-223.
Structural genomics consortium (SGC);
"The crystal structure of methyltransferase domain of human PR domain-
containing protein 1.";
Submitted (FEB-2009) to the PDB data bank.
-!- FUNCTION: Transcription factor that mediates a transcriptional
program in various innate and adaptive immune tissue-resident
lymphocyte T cell types such as tissue-resident memory T (Trm),
natural killer (trNK) and natural killer T (NKT) cells and
negatively regulates gene expression of proteins that promote the
egress of tissue-resident T-cell populations from non-lymphoid
organs. Plays a role in the development, retention and long-term
establishment of adaptive and innate tissue-resident lymphocyte T
cell types in non-lymphoid organs, such as the skin and gut, but
also in other nonbarrier tissues like liver and kidney, and
therefore may provide immediate immunological protection against
reactivating infections or viral reinfection (By similarity).
Binds specifically to the PRDI element in the promoter of the
beta-interferon gene (PubMed:1851123). Drives the maturation of B-
lymphocytes into Ig secreting cells (PubMed:12626569). Associates
with the transcriptional repressor ZNF683 to chromatin at gene
promoter regions (By similarity). {ECO:0000250|UniProtKB:Q60636,
ECO:0000269|PubMed:12626569, ECO:0000269|PubMed:1851123}.
-!- SUBUNIT: Interacts with PRMT5 (By similarity). Interacts with
FBXO10 (PubMed:24613396). Interacts with FBXO11 (PubMed:24613396,
PubMed:24968003). {ECO:0000250|UniProtKB:Q60636,
ECO:0000269|PubMed:24613396, ECO:0000269|PubMed:24968003}.
-!- INTERACTION:
O75925:PIAS1; NbExp=2; IntAct=EBI-948789, EBI-629434;
P63165:SUMO1; NbExp=2; IntAct=EBI-7839538, EBI-80140;
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q60636}.
Cytoplasm {ECO:0000269|PubMed:21421998}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=3;
Name=1;
IsoId=O75626-1; Sequence=Displayed;
Name=2;
IsoId=O75626-2; Sequence=VSP_039188;
Name=3;
IsoId=O75626-3; Sequence=VSP_043646, VSP_043647;
-!- PTM: Sumoylation at Lys-816 by PIAS1 augments transcriptional
repressor activity, and is critical for plasma cell
differentiation. {ECO:0000269|PubMed:22555612}.
-!- PTM: Ubiquitinated by the SCF(FBXO11) complex, leading to its
degradation by the proteasome. {ECO:0000269|PubMed:24613396}.
-!- SIMILARITY: Belongs to the class V-like SAM-binding
methyltransferase superfamily. {ECO:0000255|PROSITE-
ProRule:PRU00190}.
-!- SEQUENCE CAUTION:
Sequence=AAO45623.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
-!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
and Haematology;
URL="http://atlasgeneticsoncology.org/Genes/PRDM1ID41831ch6q21.html";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AF084199; AAC33300.1; -; mRNA.
EMBL; AY198414; AAO45623.1; ALT_INIT; mRNA.
EMBL; AY198415; AAO45624.1; -; mRNA.
EMBL; AL358952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL022067; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471051; EAW48419.1; -; Genomic_DNA.
EMBL; CH471051; EAW48421.1; -; Genomic_DNA.
EMBL; CH471051; EAW48422.1; -; Genomic_DNA.
EMBL; BC103832; AAI03833.1; -; mRNA.
EMBL; BC103833; AAI03834.1; -; mRNA.
EMBL; BC103834; AAI03835.1; -; mRNA.
CCDS; CCDS34505.1; -. [O75626-3]
CCDS; CCDS5054.2; -. [O75626-1]
PIR; A39564; A39564.
RefSeq; NP_001189.2; NM_001198.3. [O75626-1]
RefSeq; NP_878911.1; NM_182907.2. [O75626-3]
RefSeq; XP_011534365.1; XM_011536063.2. [O75626-2]
RefSeq; XP_016866676.1; XM_017011187.1. [O75626-2]
UniGene; Hs.436023; -.
PDB; 3DAL; X-ray; 1.65 A; A/B=38-223.
PDBsum; 3DAL; -.
ProteinModelPortal; O75626; -.
SMR; O75626; -.
BioGrid; 107108; 32.
IntAct; O75626; 7.
MINT; O75626; -.
STRING; 9606.ENSP00000358092; -.
iPTMnet; O75626; -.
PhosphoSitePlus; O75626; -.
BioMuta; PRDM1; -.
jPOST; O75626; -.
MaxQB; O75626; -.
PaxDb; O75626; -.
PeptideAtlas; O75626; -.
PRIDE; O75626; -.
ProteomicsDB; 50124; -.
ProteomicsDB; 50125; -. [O75626-2]
ProteomicsDB; 50126; -. [O75626-3]
DNASU; 639; -.
Ensembl; ENST00000369089; ENSP00000358085; ENSG00000057657. [O75626-3]
Ensembl; ENST00000369091; ENSP00000358087; ENSG00000057657. [O75626-2]
Ensembl; ENST00000369096; ENSP00000358092; ENSG00000057657. [O75626-1]
GeneID; 639; -.
KEGG; hsa:639; -.
UCSC; uc003prd.3; human. [O75626-1]
CTD; 639; -.
DisGeNET; 639; -.
EuPathDB; HostDB:ENSG00000057657.14; -.
GeneCards; PRDM1; -.
H-InvDB; HIX0006099; -.
HGNC; HGNC:9346; PRDM1.
HPA; HPA030033; -.
MIM; 603423; gene.
neXtProt; NX_O75626; -.
OpenTargets; ENSG00000057657; -.
PharmGKB; PA33707; -.
eggNOG; KOG2461; Eukaryota.
eggNOG; ENOG410ZFVU; LUCA.
GeneTree; ENSGT00940000154798; -.
HOGENOM; HOG000059670; -.
HOVERGEN; HBG053670; -.
InParanoid; O75626; -.
OMA; HCHKSYI; -.
OrthoDB; 1318335at2759; -.
PhylomeDB; O75626; -.
TreeFam; TF316545; -.
Reactome; R-HSA-6804754; Regulation of TP53 Expression.
SIGNOR; O75626; -.
ChiTaRS; PRDM1; human.
EvolutionaryTrace; O75626; -.
GeneWiki; PRDM1; -.
GenomeRNAi; 639; -.
PRO; PR:O75626; -.
Proteomes; UP000005640; Chromosome 6.
Bgee; ENSG00000057657; Expressed in 179 organ(s), highest expression level in ectocervix.
ExpressionAtlas; O75626; baseline and differential.
Genevisible; O75626; HS.
GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
GO; GO:0005634; C:nucleus; IBA:GO_Central.
GO; GO:0031490; F:chromatin DNA binding; IBA:GO_Central.
GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
GO; GO:0042826; F:histone deacetylase binding; IBA:GO_Central.
GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
GO; GO:1990841; F:promoter-specific chromatin binding; ISS:UniProtKB.
GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IBA:GO_Central.
GO; GO:0043565; F:sequence-specific DNA binding; IBA:GO_Central.
GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
GO; GO:0035904; P:aorta development; IEA:Ensembl.
GO; GO:0048844; P:artery morphogenesis; IEA:Ensembl.
GO; GO:0045165; P:cell fate commitment; IBA:GO_Central.
GO; GO:0060976; P:coronary vasculature development; IEA:Ensembl.
GO; GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl.
GO; GO:0007281; P:germ cell development; IEA:Ensembl.
GO; GO:0003170; P:heart valve development; IEA:Ensembl.
GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
GO; GO:0060576; P:intestinal epithelial cell development; IEA:Ensembl.
GO; GO:0001893; P:maternal placenta development; IEA:Ensembl.
GO; GO:0001763; P:morphogenesis of a branching structure; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
GO; GO:0042127; P:regulation of cell population proliferation; IEA:Ensembl.
GO; GO:0033082; P:regulation of extrathymic T cell differentiation; ISS:UniProtKB.
GO; GO:0032823; P:regulation of natural killer cell differentiation; ISS:UniProtKB.
GO; GO:0051136; P:regulation of NK T cell differentiation; ISS:UniProtKB.
GO; GO:1990654; P:sebum secreting cell proliferation; IEA:Ensembl.
GO; GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl.
GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
InterPro; IPR001214; SET_dom.
InterPro; IPR036236; Znf_C2H2_sf.
InterPro; IPR013087; Znf_C2H2_type.
Pfam; PF00856; SET; 1.
Pfam; PF00096; zf-C2H2; 2.
SMART; SM00317; SET; 1.
SMART; SM00355; ZnF_C2H2; 5.
SUPFAM; SSF57667; SSF57667; 3.
PROSITE; PS50280; SET; 1.
PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
1: Evidence at protein level;
3D-structure; Adaptive immunity; Alternative splicing;
Complete proteome; Cytoplasm; DNA-binding; Immunity; Innate immunity;
Isopeptide bond; Metal-binding; Methyltransferase; Nucleus;
Polymorphism; Reference proteome; Repeat; Repressor;
S-adenosyl-L-methionine; Transcription; Transcription regulation;
Transferase; Ubl conjugation; Zinc; Zinc-finger.
CHAIN 1 825 PR domain zinc finger protein 1.
/FTId=PRO_0000047757.
DOMAIN 84 201 SET. {ECO:0000255|PROSITE-
ProRule:PRU00190}.
ZN_FING 575 597 C2H2-type 1. {ECO:0000255|PROSITE-
ProRule:PRU00042}.
ZN_FING 603 625 C2H2-type 2. {ECO:0000255|PROSITE-
ProRule:PRU00042}.
ZN_FING 631 653 C2H2-type 3. {ECO:0000255|PROSITE-
ProRule:PRU00042}.
ZN_FING 659 681 C2H2-type 4. {ECO:0000255|PROSITE-
ProRule:PRU00042}.
REGION 527 574 Interaction with PIAS1.
CROSSLNK 816 816 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO1);
alternate. {ECO:0000269|PubMed:22555612}.
CROSSLNK 816 816 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2);
alternate. {ECO:0000244|PubMed:28112733}.
VAR_SEQ 1 36 Missing (in isoform 2).
{ECO:0000303|PubMed:1851123}.
/FTId=VSP_039188.
VAR_SEQ 1 3 MLD -> MEK (in isoform 3).
{ECO:0000303|PubMed:12626569,
ECO:0000303|PubMed:15489334}.
/FTId=VSP_043646.
VAR_SEQ 4 137 Missing (in isoform 3).
{ECO:0000303|PubMed:12626569,
ECO:0000303|PubMed:15489334}.
/FTId=VSP_043647.
VARIANT 74 74 G -> S (in dbSNP:rs2185379).
/FTId=VAR_019983.
VARIANT 203 203 D -> E (in dbSNP:rs811925).
/FTId=VAR_024221.
HELIX 51 57 {ECO:0000244|PDB:3DAL}.
STRAND 60 62 {ECO:0000244|PDB:3DAL}.
HELIX 78 81 {ECO:0000244|PDB:3DAL}.
STRAND 87 91 {ECO:0000244|PDB:3DAL}.
STRAND 98 105 {ECO:0000244|PDB:3DAL}.
STRAND 111 113 {ECO:0000244|PDB:3DAL}.
STRAND 119 121 {ECO:0000244|PDB:3DAL}.
TURN 123 125 {ECO:0000244|PDB:3DAL}.
STRAND 135 140 {ECO:0000244|PDB:3DAL}.
STRAND 143 149 {ECO:0000244|PDB:3DAL}.
HELIX 158 161 {ECO:0000244|PDB:3DAL}.
TURN 168 170 {ECO:0000244|PDB:3DAL}.
STRAND 173 178 {ECO:0000244|PDB:3DAL}.
STRAND 181 188 {ECO:0000244|PDB:3DAL}.
STRAND 197 200 {ECO:0000244|PDB:3DAL}.
HELIX 202 207 {ECO:0000244|PDB:3DAL}.
HELIX 218 222 {ECO:0000244|PDB:3DAL}.
SEQUENCE 825 AA; 91771 MW; 07B389BACCD6172F CRC64;
MLDICLEKRV GTTLAAPKCN SSTVRFQGLA EGTKGTMKMD MEDADMTLWT EAEFEEKCTY
IVNDHPWDSG ADGGTSVQAE ASLPRNLLFK YATNSEEVIG VMSKEYIPKG TRFGPLIGEI
YTNDTVPKNA NRKYFWRIYS RGELHHFIDG FNEEKSNWMR YVNPAHSPRE QNLAACQNGM
NIYFYTIKPI PANQELLVWY CRDFAERLHY PYPGELTMMN LTQTQSSLKQ PSTEKNELCP
KNVPKREYSV KEILKLDSNP SKGKDLYRSN ISPLTSEKDL DDFRRRGSPE MPFYPRVVYP
IRAPLPEDFL KASLAYGIER PTYITRSPIP SSTTPSPSAR SSPDQSLKSS SPHSSPGNTV
SPVGPGSQEH RDSYAYLNAS YGTEGLGSYP GYAPLPHLPP AFIPSYNAHY PKFLLPPYGM
NCNGLSAVSS MNGINNFGLF PRLCPVYSNL LGGGSLPHPM LNPTSLPSSL PSDGARRLLQ
PEHPREVLVP APHSAFSFTG AAASMKDKAC SPTSGSPTAG TAATAEHVVQ PKATSAAMAA
PSSDEAMNLI KNKRNMTGYK TLPYPLKKQN GKIKYECNVC AKTFGQLSNL KVHLRVHSGE
RPFKCQTCNK GFTQLAHLQK HYLVHTGEKP HECQVCHKRF SSTSNLKTHL RLHSGEKPYQ
CKVCPAKFTQ FVHLKLHKRL HTRERPHKCS QCHKNYIHLC SLKVHLKGNC AAAPAPGLPL
EDLTRINEEI EKFDISDNAD RLEDVEDDIS VISVVEKEIL AVVRKEKEET GLKVSLQRNM
GNGLLSSGCS LYESSDLPLM KLPPSNPLPL VPVKVKQETV EPMDP


Related products :

Catalog number Product name Quantity
18-003-44056 PR domain zinc finger protein 1 - PR domain-containing protein 1; Beta-interferon gene positive regulatory domain I-binding factor; BLIMP-1; Positive regulatory domain I-binding factor 1; PRDI-binding 0.1 mg Protein A
EIAAB32304 Beta-interferon gene positive regulatory domain I-binding factor,BLIMP1,BLIMP-1,Homo sapiens,Human,Positive regulatory domain I-binding factor 1,PR domain zinc finger protein 1,PR domain-containing pr
EIAAB32305 B lymphocyte-induced maturation protein 1,Beta-interferon gene positive regulatory domain I-binding factor,Blimp1,Blimp-1,Mouse,Mus musculus,PR domain zinc finger protein 1,PR domain-containing protei
28-769 PRDM1 is a protein that acts as a repressor of beta-interferon gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the beta-IFN gene promoter. Transcr 0.1 mg
18-003-44039 LIM domain-binding protein 1 - Nuclear LIM interactor; Carboxyl-terminal LIM domain-binding protein 2; CLIM-2; LIM domain-binding factor CLIM2; hLdb1 Polyclonal 0.05 mg Aff Pur
18-003-42715 Zinc finger and BTB domain-containing protein 7A - Leukemia_lymphoma-related factor; Factor that binds to inducer of short transcripts protein 1; Factor binding IST protein 1; FBI-1; HIV-1 1st-binding 0.1 mg Protein A
18-003-43098 LIM domain-binding protein 2 - Carboxyl-terminal LIM domain-binding protein 1; CLIM-1; LIM domain-binding factor CLIM1 Polyclonal 0.1 mg Protein A
18-003-42854 LIM domain-binding protein 2 - Carboxyl-terminal LIM domain-binding protein 1; CLIM-1; LIM domain-binding factor CLIM1 Polyclonal 0.1 mg Protein A
15-288-21968A Zinc finger protein 395 - Papillomavirus-binding factor; Papillomavirus regulatory factor 1; PRF-1; Huntington disease gene regulatory region-binding protein 2; HDBP-2; HD gene regulatory region-bindi 0.1 mg
10-288-21968F Zinc finger protein 395 - Papillomavirus-binding factor; Papillomavirus regulatory factor 1; PRF-1; Huntington disease gene regulatory region-binding protein 2; HDBP-2; HD gene regulatory region-bindi 0.1 mg
10-288-21968F Zinc finger protein 395 - Papillomavirus-binding factor; Papillomavirus regulatory factor 1; PRF-1; Huntington disease gene regulatory region-binding protein 2; HDBP-2; HD gene regulatory region-bindi 0.05 mg
18-003-43101 Zinc finger protein 395 - Papillomavirus-binding factor; Papillomavirus regulatory factor 1; PRF-1; Huntington disease gene regulatory region-binding protein 2; HDBP-2; HD gene regulatory region-bindi 0.05 mg Aff Pur
15-288-21968A Zinc finger protein 395 - Papillomavirus-binding factor; Papillomavirus regulatory factor 1; PRF-1; Huntington disease gene regulatory region-binding protein 2; HDBP-2; HD gene regulatory region-bindi 0.05 mg
15-288-21968B Zinc finger protein 395 - Papillomavirus-binding factor; Papillomavirus regulatory factor 1; PRF-1; Huntington disease gene regulatory region-binding protein 2; HDBP-2; HD gene regulatory region-bindi 0.1 mg
15-288-21968B Zinc finger protein 395 - Papillomavirus-binding factor; Papillomavirus regulatory factor 1; PRF-1; Huntington disease gene regulatory region-binding protein 2; HDBP-2; HD gene regulatory region-bindi 0.05 mg
EIAAB34440 DNA-binding protein RFX7,Homo sapiens,Human,Regulatory factor X 7,Regulatory factor X domain-containing protein 2,RFX7,RFXDC2
EIAAB34439 DNA-binding protein RFX6,Homo sapiens,Human,Regulatory factor X 6,Regulatory factor X domain-containing protein 1,RFX6,RFXDC1
EIAAB34438 DNA-binding protein RFX6,Mouse,Mus musculus,Regulatory factor X 6,Regulatory factor X domain-containing protein 1,Rfx6,Rfxdc1
EIAAB47434 HD gene regulatory region-binding protein 2,HDBP2,HDBP-2,HD-regulating factor 2,HDRF-2,Homo sapiens,Human,Huntington disease gene regulatory region-binding protein 2,Papillomavirus regulatory factor 1
EIAAB32306 GATA-3-binding protein G3B,Homo sapiens,Human,KMT8,Lysine N-methyltransferase 8,MTB-ZF,MTE-binding protein,PR domain zinc finger protein 2,PR domain-containing protein 2,PRDM2,Retinoblastoma protein-i
E1602h ELISA Homo sapiens,Human,OCT6,Oct-6,Octamer-binding protein 6,Octamer-binding transcription factor 6,OTF6,OTF-6,POU domain transcription factor SCIP,POU domain, class 3, transcription factor 1,POU3F1 96T
U1602h CLIA Homo sapiens,Human,OCT6,Oct-6,Octamer-binding protein 6,Octamer-binding transcription factor 6,OTF6,OTF-6,POU domain transcription factor SCIP,POU domain, class 3, transcription factor 1,POU3F1 96T
25-416 RFX1 is a member of the regulatory factor X protein family, which are transcription factors that contain a highly-conserved winged helix DNA binding domain. RFX1 is structurally related to regulatory 0.05 mg
E1602h ELISA kit Homo sapiens,Human,OCT6,Oct-6,Octamer-binding protein 6,Octamer-binding transcription factor 6,OTF6,OTF-6,POU domain transcription factor SCIP,POU domain, class 3, transcription factor 1,PO 96T
31-202 Interferon regulatory factor 8 (IRF8, interferon consensus sequence-binding protein, Ion ChannelSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this 0.05 mg

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP731: Sterol regulatory element binding protein related
WP1689: Porphyrin and chlorophyll metabolism
WP1789: Binding of RNA by Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs)
WP1899: Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs)
WP1531: Vitamin D synthesis
WP1616: ABC transporters
WP2292: Chemokine signaling pathway
WP1493: Carbon assimilation C4 pathway
WP1909: Signal regulatory protein (SIRP) family interactions
WP2199: Seed Development
WP1046: Signaling of Hepatocyte Growth Factor Receptor
WP1162: Signaling of Hepatocyte Growth Factor Receptor
WP1206: Signaling of Hepatocyte Growth Factor Receptor
WP1235: Signaling of Hepatocyte Growth Factor Receptor
WP1566: Citrate cycle (TCA cycle)
WP1825: GPCR ligand binding
WP1869: Neuroransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
WP193: Signaling of Hepatocyte Growth Factor Receptor
WP1983: Splicing factor NOVA regulated synpatic proteins
WP210: Cytoplasmic Ribosomal Proteins
WP2148: Brain derived neurotrophic factor
WP2218: sGC
WP272: Blood Clotting Cascade
WP313: Signaling of Hepatocyte Growth Factor Receptor
WP444: Signaling of Hepatocyte Growth Factor Receptor

Related Genes :
[PRDM1 BLIMP1] PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1)
[Prdm1 Blimp1] PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1)
[HIVEP1 ZNF40] Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1)
[] Genome polyprotein [Cleaved into: Capsid protein C (Capsid protein) (Core protein); Protein prM (Precursor membrane protein); Peptide pr (Peptide precursor); Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[] Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[] Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Non-structural protein 2A-alpha (NS2A-alpha); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[GP1 MZ11_60484gpGP1 MZ11_60553gpGP1] Genome polyprotein [Cleaved into: Peptide 2k; Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (NS5)]
[] Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[] Genome polyprotein [Cleaved into: Protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Non-structural protein 2A-alpha (NS2A-alpha); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[PRDM16 KIAA1675 MEL1 PFM13] PR domain zinc finger protein 16 (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1)
[Prdm16 Kiaa1675 Mel1] PR domain zinc finger protein 16 (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1)
[env] Envelope glycoprotein gp160 (Env polyprotein) [Cleaved into: Surface protein gp120 (SU) (Glycoprotein 120) (gp120); Transmembrane protein gp41 (TM) (Glycoprotein 41) (gp41)]
[] Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[] Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[] Genome polyprotein [Cleaved into: Peptide 2k; Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[] Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (NS5)] (Fragment)
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (Leader protein); Non-structural protein 2 (nsp2) (p65 homolog); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL2-PRO) (Papain-like proteinase) (PL-PRO) (SARS coronavirus main proteinase); Non-structural protein 4 (nsp4); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (nsp5); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7); Non-structural protein 8 (nsp8); Non-structural protein 9 (nsp9); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL); Non-structural protein 11 (nsp11)]
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL1-PRO/PL2-PRO) (PL1/PL2) (Papain-like proteinases 1/2) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); Non-structural protein 11 (nsp11)]
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL1-PRO/PL2-PRO) (PL1/PL2) (Papain-like proteinases 1/2) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); Non-structural protein 11 (nsp11)]
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[Taf1 Ccg1] Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250)
[gag-pro-pol] Gag-Pro-Pol polyprotein (Pr160Gag-Pro-Pol) [Cleaved into: Matrix protein p19 (MA); Capsid protein p24 (CA); Nucleocapsid protein p15-pro (NC') (NC-pro); Protease (PR) (EC 3.4.23.-); p1; Reverse transcriptase/ribonuclease H, p49 subunit (p49 RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Reverse transcriptase/ribonuclease H, p62 subunit (p62 RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL1-PRO/PL2-PRO) (PL1/PL2) (Papain-like proteinases 1/2) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); Non-structural protein 11 (nsp11)]
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]

Bibliography :
?>